Form 4 for APVO Aptevo Therapeutics Inc.
Accepted 2023-03-07 00:00:00 ET · period of report 2023-03-03 · accession 0001209191-23-016783 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-07 | 2023-03-04 | APVO | Taylor Daphne | SVP, CFO | M - OptEx | — | +1,583 | 5,423 | +41% | — |
| DM | 2023-03-07 | 2023-03-03 | APVO | Taylor Daphne | SVP, CFO | A - Grant | $0.00 | +22.0K | 11.0K | New | $0 |
| D | 2023-03-07 | 2023-03-04 | APVO | Taylor Daphne | SVP, CFO | M - OptEx | $0.00 | -1,583 | 3,167 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-04 | M | A | 1,583 | — | 5,423 | D | — | — | (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Unit | 2023-03-03 | A | A | 11,000 | $0.00 | 11,000 | D | — · — to — | 11,000 Common Stock | (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F3) The RSUs vest in three approximately equal annual installments beginning on March 2, 2024. |
| 3 | Derivative | Stock Option (right to buy) | 2023-03-03 | A | A | 11,000 | $0.00 | 11,000 | D | $2.15 · — to 2033-03-02 | 11,000 Common Stock | (F2) The option vests in three approximately equal annual installments beginning on March 2, 2024. |
| 4 | Derivative | Restricted Stock Unit | 2023-03-04 | M | D | 1,583 | $0.00 | 3,167 | D | — · — to — | 1,583 Common Stock | (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F4) On June 7, 2022, the reporting person was granted 4,750 RSUs, vesting in three approximately equal annual installments beginning on March 4, 2023. |